FHIR IG analytics| Package | hl7.fhir.uv.ebm |
| Resource Type | Group |
| Id | Group-438155.json |
| FHIR Version | R6 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
[No data.]
FHIR
FHIRsmith{
"resourceType": "Group",
"id": "438155",
"meta": {
"versionId": "30",
"lastUpdated": "2026-08-15T16:22:59.044Z",
"profile": [
"http://hl7.org/fhir/uv/ebm/StructureDefinition/study-eligibility-criteria"
]
},
"text": {
"status": "empty",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as",
"valueMarkdown": "CTIS2025-523977-40-00 Eligibility Criteria - ARMYDA Study on Coronary Plaque Change with Semaglutide in Diabetes with ACS [Database Entry: FHIR Group Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 438155. Revised 2026-08-15. Available at: https://fevir.net/resources/Group/438155. Computable resource at: https://fevir.net/resources/Group/438155#json."
},
{
"url": "http://hl7.org/fhir/StructureDefinition/artifact-author",
"valueContactDetail": {
"name": "Brian S. Alper, MD, MSPH"
}
},
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
"valueCodeableConcept": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
"code": "active",
"display": "Active"
}
]
}
}
],
"url": "https://fevir.net/resources/Group/438155",
"identifier": [
{
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0203",
"code": "ACSN",
"display": "Accession ID"
}
],
"text": "FEvIR Object Identifier"
},
"system": "https://fevir.net/FOI",
"value": "438155",
"assigner": {
"display": "Computable Publishing LLC"
}
}
],
"name": "ARMYDA_Eligibility_Criteria",
"title": "CTIS2025-523977-40-00 Eligibility Criteria - ARMYDA Study on Coronary Plaque Change with Semaglutide in Diabetes with ACS",
"publisher": "Computable Publishing LLC",
"contact": [
{
"telecom": [
{
"system": "email",
"value": "support@computablepublishing.com"
}
]
}
],
"description": "This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide.",
"copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"type": "person",
"membership": "definitional",
"combinationMethod": "all-of",
"characteristic": [
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching",
"valueBoolean": true
}
],
"code": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "64572001",
"display": "Disease (disorder)"
}
]
},
"valueCodeableConcept": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "44054006",
"display": "Diabetes mellitus type 2 (disorder)"
}
]
},
"exclude": false,
"description": "Diagnosis of T2DM"
},
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching",
"valueBoolean": true
}
],
"code": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "64572001",
"display": "Disease (disorder)"
}
]
},
"valueCodeableConcept": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "401314000",
"display": "Acute non-ST segment elevation myocardial infarction (disorder)"
}
]
},
"exclude": false,
"description": "Non-ST-segment elevation ACS"
},
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching",
"valueBoolean": false
}
],
"code": {
"text": "Defined by CodeableConcept"
},
"valueCodeableConcept": {
"text": "Presence of one identifiable culprit coronary lesion treated with percutaneous coronary intervention (PCI)"
},
"exclude": false,
"description": "Presence of one identifiable culprit coronary lesion treated with percutaneous coronary intervention (PCI)"
},
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching",
"valueBoolean": false
}
],
"code": {
"text": "Defined by CodeableConcept"
},
"valueCodeableConcept": {
"text": "Presence of at least one non-culprit, mild to intermediate stenosis (30% to 69% lumen narrowing) at coronary angiography, with a macrophage arc detectable on optical coherence tomography (OCT), on a major epicardial coronary artery different from the culprit vessel"
},
"exclude": false,
"description": "Presence of at least one non-culprit, mild to intermediate stenosis (30% to 69% lumen narrowing) at coronary angiography, with a macrophage arc detectable on optical coherence tomography (OCT), on a major epicardial coronary artery different from the culprit vessel"
},
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching",
"valueBoolean": true
}
],
"code": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "397669002",
"display": "Age"
}
]
},
"valueQuantity": {
"value": 40,
"comparator": ">=",
"unit": "years",
"system": "http://unitsofmeasure.org",
"code": "a"
},
"exclude": false,
"description": "Age ≥40 years"
},
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching",
"valueBoolean": false
}
],
"code": {
"text": "Defined by CodeableConcept"
},
"valueCodeableConcept": {
"text": "Signed informed consent."
},
"exclude": false,
"description": "Signed informed consent."
},
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching",
"valueBoolean": true
}
],
"code": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "64572001",
"display": "Disease (disorder)"
}
]
},
"valueCodeableConcept": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "10633002",
"display": "Acute congestive heart failure (disorder)"
}
]
},
"exclude": true,
"description": "Acute heart failure"
},
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching",
"valueBoolean": true
}
],
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "45066-8",
"display": "Creatinine and Glomerular filtration rate.predicted panel - Serum, Plasma or Blood"
}
],
"text": "Creatinine & Glomerular filtration rate.predicted panel:-:Pt:Ser/Plas/Bld:Qn"
},
"valueQuantity": {
"value": 30,
"comparator": "<",
"unit": "mL/min/1.73 m²"
},
"exclude": true,
"description": "Renal dysfunction (estimated GFR <30 mL/min/1.73 m²)"
},
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching",
"valueBoolean": true
}
],
"code": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "71388002",
"display": "Procedure (procedure)"
}
]
},
"valueCodeableConcept": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "108241001",
"display": "Dialysis procedure (Procedure)"
}
]
},
"exclude": true,
"description": "Renal dysfunction (on dialysis)"
},
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching",
"valueBoolean": true
}
],
"code": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "64572001",
"display": "Disease (disorder)"
}
]
},
"valueCodeableConcept": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "75694006",
"display": "Pancreatitis (disorder)"
}
]
},
"exclude": true,
"description": "History of pancreatitis.",
"relativeTime": [
{
"contextCode": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "709491003",
"display": "Enrollment in clinical trial (procedure)"
}
]
},
"offsetDuration": {
"value": 0,
"comparator": "<=",
"unit": "seconds",
"system": "http://unitsofmeasure.org",
"code": "s"
}
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching",
"valueBoolean": false
}
],
"code": {
"text": "Defined by CodeableConcept"
},
"valueCodeableConcept": {
"text": "High risk of pancreatitis."
},
"exclude": true,
"description": "High risk of pancreatitis."
},
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching",
"valueBoolean": false
}
],
"code": {
"text": "Defined by CodeableConcept"
},
"valueCodeableConcept": {
"text": "Severe gastroparesis requiring therapy <6 months prior to randomization."
},
"exclude": true,
"description": "Severe gastroparesis requiring therapy <6 months prior to randomization."
},
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching",
"valueBoolean": false
}
],
"code": {
"text": "Defined by CodeableConcept"
},
"valueCodeableConcept": {
"text": "Active malignancy or history of neuroendocrine tumors."
},
"exclude": true,
"description": "Active malignancy or history of neuroendocrine tumors."
},
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching",
"valueBoolean": false
}
],
"code": {
"text": "Defined by CodeableConcept"
},
"valueCodeableConcept": {
"text": "Hypersensitivity or contraindications to semaglutide or its excipients."
},
"exclude": true,
"description": "Hypersensitivity or contraindications to semaglutide or its excipients."
},
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching",
"valueBoolean": true
}
],
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "76625-3",
"display": "Alanine aminotransferase [Enzymatic activity/volume] in Blood"
}
]
},
"valueQuantity": {
"value": 2,
"comparator": ">",
"unit": "upper limit of normal",
"system": "http://hl7.org/fhir/characteristic-offset",
"code": "UNL"
},
"exclude": true,
"description": "Severe hepatic dysfunction (ALT >2× upper limit of normal)."
},
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching",
"valueBoolean": true
}
],
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "1920-8",
"display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
}
],
"text": "Aspartate aminotransferase [Enzymatic activity/volume] in Blood"
},
"valueQuantity": {
"value": 2,
"comparator": ">",
"unit": "upper limit of normal",
"system": "http://hl7.org/fhir/characteristic-offset",
"code": "UNL"
},
"exclude": true,
"description": "Severe hepatic dysfunction (AST >2× upper limit of normal)."
},
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching",
"valueBoolean": true
}
],
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "1975-2",
"display": "Bilirubin.total [Mass/volume] in Serum or Plasma"
}
],
"text": "Total Bilirubin in Serum or Plasma (measured by mass/volume, e.g., mg/dL)"
},
"valueQuantity": {
"value": 1.5,
"comparator": ">",
"unit": "upper limit of normal",
"system": "http://hl7.org/fhir/characteristic-offset",
"code": "UNL"
},
"exclude": true,
"description": "Severe hepatic dysfunction (total bilirubin >1.5× upper limit of normal)."
},
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching",
"valueBoolean": false
}
],
"code": {
"text": "Defined by CodeableConcept"
},
"valueCodeableConcept": {
"text": "Pregnancy or breastfeeding. Women of childbearing potential must have a negative pregnancy test at screening and agree to use effective contraception during the study."
},
"exclude": true,
"description": "Pregnancy or breastfeeding. Women of childbearing potential must have a negative pregnancy test at screening and agree to use effective contraception during the study."
},
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching",
"valueBoolean": true
}
],
"code": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "64572001",
"display": "Disease (disorder)"
}
]
},
"valueCodeableConcept": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "420422005",
"display": "Ketoacidosis due to diabetes mellitus (disorder)"
}
]
},
"exclude": true,
"description": "Patients with diabetic ketoacidosis"
},
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching",
"valueBoolean": true
}
],
"code": {
"coding": [
{
"system": "http://hl7.org/fhir/fhir-types",
"code": "MedicationRequest",
"display": "MedicationRequest"
}
]
},
"valueCodeableConcept": {
"coding": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"code": "1991302",
"display": "semaglutide"
}
]
},
"exclude": true,
"description": "Use of semaglutide at screening within 30 days prior to randomization.",
"relativeTime": [
{
"contextCode": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "709491003",
"display": "Enrollment in clinical trial (procedure)"
}
]
},
"offsetRange": {
"low": {
"value": -30,
"unit": "days",
"system": "http://unitsofmeasure.org",
"code": "d"
},
"high": {
"value": 0
}
}
}
]
},
{
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/relevant-for-automated-matching",
"valueBoolean": false
}
],
"code": {
"text": "Defined by CodeableConcept"
},
"valueCodeableConcept": {
"text": "Inability to provide informed consent."
},
"exclude": true,
"description": "Inability to provide informed consent."
}
]
}